All Circulars (26472)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE suspends trading in two commercial paper instruments of SBICAP Securities Limited due to upcoming redemption with record dates on … | |||||||||||||||
BSE suspends trading in two commercial paper instruments of SBICAP Securities Limited due to upcoming redemption with record dates on December 19 and 22, 2025.
| |||||||||||||||
Trading suspended in two commercial papers of SBICAP Securities Limited due to redemption. No dealings from December 19 and 22, 2025 … | |||||||||||||||
Trading suspended in two commercial papers of SBICAP Securities Limited due to redemption. No dealings from December 19 and 22, 2025 respectively.
| |||||||||||||||
Trading suspended for two commercial papers of SBICAP Securities Limited due to upcoming redemptions on December 19 and 22, 2025. | |||||||||||||||
Trading suspended for two commercial papers of SBICAP Securities Limited due to upcoming redemptions on December 19 and 22, 2025.
| |||||||||||||||
NSE suspends trading in ARSS Infrastructure Projects Limited (ARSSINFRA) effective December 19, 2025, due to capital reduction pursuant to … | |||||||||||||||
NSE suspends trading in ARSS Infrastructure Projects Limited (ARSSINFRA) effective December 19, 2025, due to capital reduction pursuant to NCLT order dated August 29, 2025.
| |||||||||||||||
NSE notifies commencement of trading in Rights Entitlements of NACL Industries Limited from December 22, 2025 to December 24, 2025 in Trade … | |||||||||||||||
NSE notifies commencement of trading in Rights Entitlements of NACL Industries Limited from December 22, 2025 to December 24, 2025 in Trade to Trade segment.
| |||||||||||||||
Vivimed Labs Limited (VIVIMEDLAB) will be transferred from BE series to EQ series effective December 26, 2025. | |||||||||||||||
Vivimed Labs Limited (VIVIMEDLAB) will be transferred from BE series to EQ series effective December 26, 2025.
| |||||||||||||||
BSE announces addition of four newly listed companies to BSE IPO and BSE SME IPO indices effective December 18-19, 2025. | |||||||||||||||
BSE announces addition of four newly listed companies to BSE IPO and BSE SME IPO indices effective December 18-19, 2025.
| |||||||||||||||
Four companies being added to BSE indices: Park Medi World and Nephrocare Health Services to BSE IPO index, Shipwaves Online and Unisem … | |||||||||||||||
Four companies being added to BSE indices: Park Medi World and Nephrocare Health Services to BSE IPO index, Shipwaves Online and Unisem Agritech to BSE SME IPO index.
| |||||||||||||||
BSE announces the addition of four newly listed companies to BSE indices: two companies added to BSE IPO index effective December 19, 2025, … | |||||||||||||||
BSE announces the addition of four newly listed companies to BSE indices: two companies added to BSE IPO index effective December 19, 2025, and two companies added to BSE SME IPO index effective December 18, 2025.
| |||||||||||||||
SEBI adjudication proceedings against Dr. Anil Arora (erstwhile CFO), Mr. Bharat Bhushan Mehta (then CFO), and Mr. Ashok Kumar Shukla (then … | |||||||||||||||
SEBI adjudication proceedings against Dr. Anil Arora (erstwhile CFO), Mr. Bharat Bhushan Mehta (then CFO), and Mr. Ashok Kumar Shukla (then Company Secretary) for alleged insider trading violations in Mawana Sugars Limited during September 2017 to February 2018.
| |||||||||||||||